On June 18, 2025, FDA announced for public comment a Post-market Assessment Prioritization Tool (Prioritization Tool) as an enhanced systematic process for post-market scientific assessment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback